Mobic
New Arthritis Drug Xeljanz Gets FDA Approval »
"Nov. 6, 2012 -- The FDA has approved Pfizer's Xeljanz (tofacitinib), a first-of-its-kind treatment for rheumatoid arthritis.
Xeljanz is approved for use by patients not helped by methotrexate, the usual first treatment for RA. It's a "...
Read the New Arthritis Drug Xeljanz Gets FDA Approval article »
Mobic
PATIENT INFORMATION
No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.
Last reviewed on RxList: 3/13/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Mobic Information
Mobic - User Reviews
Mobic User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Here is a collection of user reviews for the medication Mobic sorted by most helpful.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Arthritis
Get the latest treatment options
Updated & New
